Breaking News

Stevanato Group Secures €130 Million in ESG-Linked Financing

An additional €60M financed by CDP will support investments in technology innovation, state-of-the-art machinery, and the modernization of a production plant.

Stevanato Group S.p.A., a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced two separate agreements with BNL BNP Paribas and Cassa Depositi e Prestiti Group (CDP) to obtain ESG-linked funds to support its ongoing global expansion. BNL BNP Paribas is participating in the financing with a contribution of €70 million, which is tied to two ESG-related objectives including increasing the company’...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters